Vasorelaxant Effect of 5'-Methylthioadenosine Obtained from Candida utilis Yeast Extract through the Suppression of Intracellular Ca(2+) Concentration in Isolated Rat Aorta.

Our study is the first to demonstrate the vasorelaxant effect of Candida utilis yeast extract on rat aorta (EC50 of 7.2 ± 3.2 mg/mL). Among five identified compounds, 5'-methylthioadenosine (MTA) exhibited comparable vasorelaxant effect (EC50 of 190 ± 40 µM) with adenosine, a known vasodilator, on 1 µM phenylephrine (PE)-contracted Sprague-Dawley rat aortic rings. MTA induced vasorelaxation in an endothelium-independent manner and independent of the adenosine receptors. MTA reduced a CaCl2-induced vasocontraction stimulated by 1 µM PE, whereas the effect was abolished in a 60 mM KCl-induced vasocontraction. This indicates that MTA was not involved in the suppression of extracellular Ca(2+) influx. MTA significantly (P < 0.01) attenuated the PE-induced activation of calmodulin-dependent kinase II (CaMK II) in aortic rings and inhibited the phosphorylation of L-type Ca(2+) channel (VDCC). In conclusion, the underlying mechanism(s) of MTA-induced vasorelaxation involves the inhibition of Ca(2+)/CaMK II/VDCC phosphorylation pathway, resulting in the suppression of intracellular Ca(2+) concentration in aortic rings.

Elution profile of di-peptides on a sulfonated ethylstyrene-divinylbenzene copolymer resin column by high-performance liquid chromatography.

This study investigates the characteristics of a partially sulfonated ethylstyrene-divinylbenzene copolymer for the separation of di-peptides by high-performance liquid chromatography. Di-peptides (VE, VA, VH, VK, and VR) with different isoelectric points (pI, 4.0 to 9.7) and log P values (-1.63 to -0.72) were used to optimize the separation conditions of the columns packed with sulfonated copolymer resin. The retention factor (k) of the di-peptides on the column with a 0.81 wt% sulfo group content decreased with increasing concentrations of phosphate salts (2.5 - 20 mmol L(-1)) in the mobile phase. The complete separation of the five di-peptides was obtained with a gradient of 10% methanol containing 5 mmol L(-1) NaH2PO4 (pH 4.8) to 50% methanol containing 5 mmol L(-1) Na2HPO4 (pH 8.9) for 60 min at 0.5 mL min(-1) at 50°C. Under the optimal conditions, a good relationship between the k and pI values of the di-peptides, with the exception of VE (pI 4.0), was observed, suggesting that the retention of the di-peptides on the column packed with sulfonated copolymer resin was dependent on the pI value, when it was greater than 5. The log P value also influenced the separation characteristics of the column; peptides possessing the same pI value (6.4 for GH, VH, IH, and FH) showed a higher retention on the column with increasing log P values. In conclusion, the prototype sulfonated ethylstyrene-divinylbenzene copolymer column was applicable for the separation of basic di-peptides, and the separation depended on the pI and hydrophobicity of the di-peptides.

Inhibition of calcium-calmodulin complex formation by vasorelaxant basic dipeptides demonstrated by in vitro and in silico analyses.

BACKGROUND: Tryptophan-histidine (Trp-His) was found to suppress the activity of the Ca²âº/calmodulin (CaM)-dependent protein kinases II (CaMKII), which requires the Ca²âº-CaM complex for an initial activation. In this study, we attempted to clarify whether Trp-His inhibits Ca²âº-CaM complex formation, a CaMKII activator. METHODS: The ability of Trp-His and other peptides to inhibit Ca²âº-CaM complex formation was investigated by a Ca²âº-encapsulation fluorescence assay. The peptide-CaM interactions were illustrated by molecular dynamic simulation. RESULTS: We showed that Trp-His inhibited Ca²âº-CaM complex formation with a 1:1 binding stoichiometry of the peptide to CaM, considering that Trp-His reduced Hill coefficient of Ca²âº-CaM binding from 2.81 to 1.92. His-Trp also showed inhibitory activity, whereas Trp+His, 3-methyl His-Trp, and Phe-His did not show significant inhibitory activity, suggesting that the inhibitory activity was due to a peptide skeleton (irrespective of the sequence), a basic amino acid, a His residue, the N hydrogen atom of its imidazole ring, and Trp residue. In silico studies suggested the possibility that Trp-His and His-Trp interacted with the Ca²âº-binding site of CaM by forming hydrogen bonds with key Ca²âº-binding residues of CaM, with a binding free energy of -49.1 and -68.0 kJ/mol, respectively. CONCLUSIONS: This is the first study demonstrating that the vasoactive dipeptide Trp-His possesses inhibitory activity against Ca²âº-CaM complex formation, which may elucidate how Trp-His inhibited CaMKII in a previous study. GENERAL SIGNIFICANCE: The results provide a basic idea that could lead to the development of small peptides binding with high affinity to CaM and inhibiting Ca²âº-CaM complex formation in the future.

Identification of peptides from soybean protein, glycinin, possessing suppression of intracellular Ca2+ concentration in vascular smooth muscle cells.

In this study, we challenged to identify vasoactive peptides in soybean 11S glycinin hydrolysate by thermolysin to regulate intracellular Ca(2+) concentration ([Ca(2+)]i) that can induce constrictive vascular tension. As a function of the inhibition of elevated [Ca(2+)]i by 10 µM angiotensin (Ang) II in vascular smooth muscle cells (VSMCs), eleven peptides were successfully identified from the hydrolysate, among which His-Gly-Lys exhibited the most potent inhibition against [Ca(2+)]i elevation in Ang II-stimulated VSMCs (inhibition at 300 µM: 46.5±8.0% vs. control). The biological capacity of His-Gly-Lys analogues as an [Ca(2+)]i inhibitor was also proven when His-Lys and His-Gly-Arg elicited a significant reduction in [Ca(2+)]i. In contrast, less reduction of [Ca(2+)]i by His-Gly-Ile and His-(3-methyl)-Gly-Lys indicated the importance of the imino proton in His, along with basic amino acids positioned at C-terminal for the effect.